Global Inactivated Vaccines Market Size and Forecast to 2029: Revenue, Growth, and Trends

Uncover key drivers, emerging technologies, and competitive movements shaping the inactivated vaccines market from 2025–2034 with trusted insights from The Business Research Company

How Big Is The Inactivated Vaccines Market Size Today And What Will Its Value Be At The End Of 2029?

The inactivated vaccines market has shown consistent expansion in its size during recent years. Its value is anticipated to rise from $6.19 billion in 2024 to $6.37 billion in 2025, reflecting a compound annual growth rate (CAGR) of 2.8%. Factors contributing to this growth historically include polio eradication efforts, influenza vaccination programs, the emergence of infectious diseases, and various regulatory approvals.

The inactivated vaccines market size is projected to experience consistent expansion over the upcoming years. This market is anticipated to reach $7.58 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 4.5%. Key factors driving this growth during the forecast period include efforts in pandemic preparedness, the widening scope of vaccine coverage, progress in biomanufacturing, and various health equity initiatives. Significant trends observed during this period encompass mrna vaccine platforms, the development of combination vaccines, thermostable vaccine technologies, and the implementation of digital vaccine passports.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13018&type=smp

Which Key Drivers Are Powering Growth In The Inactivated Vaccines Market?

The inactivated vaccine market is anticipated to expand due to the rising occurrence of infectious diseases. These illnesses, characterized by their person-to-person spread, stem from pathogens like bacteria, viruses, fungi, or parasites, manifesting in diverse symptoms and health issues. Tuberculosis represents one form of infectious disease. Inactivated vaccines function by employing non-living pathogens to induce an immune response, thereby offering effective prevention against conditions like polio, hepatitis A, and influenza. To illustrate, data from November 2023, published by the US-based national public health agency, Centers for Disease Control and Prevention, showed a rise in tuberculosis cases within the USA, climbing from 8,320 in 2022 to 9,615 in 2023, signifying an increase of 1,295 cases. Consequently, the increasing prevalence of infectious diseases is a significant driver for the growth of the inactivated vaccine market.

Which Segment Categories Are Driving Maximum Growth In The Inactivated Vaccines Market?

The inactivated vaccines market covered in this report is segmented –

1) By Type: Viral Vaccine, Bacterial Vaccine

2) By Method Of Inactivation: Solvent Detergent, Radiation, pH Concentration, Heat Inactivation, Other Methods Of Inactivation

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels

Subsegments:

1) By Viral Vaccine: Inactivated Poliovirus Vaccine (IPV), Inactivated Influenza Vaccine, Inactivated Hepatitis A Vaccine, Inactivated Rabies Vaccine

2) By Bacterial Vaccine: Inactivated Typhoid Vaccine, Inactivated Cholera Vaccine, Inactivated Pertussis Vaccine, Inactivated Plague Vaccine

What Key Trends Are Driving Growth In The Inactivated Vaccines Market?

Leading firms within the inactivated vaccines market are launching novel and sophisticated inactivated vaccines to maintain their competitive standing. An inactivated vaccine comprises virus particles, bacteria, or other pathogens that have been cultured and then rendered inactive, thereby eliminating their capacity to cause disease. For example, in January 2022, UK-based pharmaceutical and biotechnology company GSK PLC introduced Shingrix, a new inactivated vaccine designed to protect against shingles (Herpes zoster). Shingrix is a non-live, recombinant subunit adjuvanted vaccine administered intramuscularly in two doses. Initially, the vaccine was indicated for individuals 50 years and older. More recently, its scope has been broadened to include individuals 18 and older who are at increased risk of developing shingles because of immunodeficiency or immunosuppression resulting from a known disease or medical treatment.

Who Are The Leading Companies Driving The Inactivated Vaccines Market?

Major companies operating in the inactivated vaccines market are Pfizer Inc., Johnson & Johnson Services Inc., Sinopharm Group Co. Ltd., Merck & Co. Inc., Sanofi S.A., GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Astellas Pharma Inc., CSL Limited, Daiichi Sankyo Company Limited, Mitsubishi Tanabe Pharma Corporation, Novavax Inc., Zydus Lifesciences Ltd., Sinovac Biotech Ltd., Biological E Limited, Hualan Biological Engineering Inc., CanSino Biologics Inc., Shenzhen Kangtai Biological Products Co. Ltd., Serum Institute of India Pvt. Ltd., Beijing Tiatan Biological Products Co. Ltd., Valneva SE, Bavarian Nordic A/S., Beijing Minhai Biotechnology Co. Ltd., Bharat Biotech International Limited, Panacea Biotec Ltd., Sinergium Biotech SA, Bharat Immunologicals and Biologicals Corporation Limited, Haffkine Biopharmaceutical Corporation Limited, Incepta Vaccine Ltd., Changchun BCHT Biotechnology Co. Ltd., .

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/inactivated-vaccines-global-market-report

Which Region Holds The Largest Share In The Inactivated Vaccines Market Today?

North America was the largest region in the inactivated vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in inactivated vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=13018&type=smp

Browse Through More Reports Similar to the Global Inactivated Vaccines Market 2025, By The Business Research Company

Cancer Vaccine Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cancer-vaccine-global-market-report

Dtp Vaccine Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/dtp-vaccine-global-market-report

Companion Animal Veterinary Vaccines Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/companion-animal-veterinary-vaccines-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795